MV OIL TRUST DL-,01 WKN: A0RCH9 ISIN: US5538591091 Forum: Aktien Thema: Hauptdiskussion

Kommt auch grad im Morgenmagazin..... 1,5 Fach mehr lng Gas als vorher durch Russland importiert. Tja, vorher war der Bedarf aber auch niedriger weil Kohle, Atom Kraftwerke ja abgeschaltet werden sollen. Der Energiebedarf steigt aber durch die Elektrifizierung in den nächsten Jahren stark an. Reserven in der Infrastruktur sind wichtig 😉

sind LNG überdimensioniert? https://www.tagesschau.de/wirtschaft/technologie/lng-terminals-studie-101.html

Guten Morgen liebe Ölis 🥰👋👋👋😎🍀🥳💰

Aber, - alles verstanden 👍🙂

oh Gott, Willy 🤣🤣🤣🤣🤣🤣🤣🤣🤣🙈

Ich will ja noch teuer verkaufen falls ich das mit dem Brokerwechsel nicht mehr schaffen sollte 😅 also alles richtig so. Verstehen kann ich das zwar auch nicht so richtig da der Ölpreis weiter fällt aber ok. Besser ich verstehe das nicht, als das ich verstehe warum andere Aktien fallen, während alle anderen das wiederum nicht verstehen. Falls jemand verstanden hat was ich meinte 😅 aber falls nicht, verstehe ich das auch 🤣🤣🤣🤣🙈

Zum verrückt werden

Und, Ihr seid sicher, daß mvo wieder runtergeht? Habe nun nämlich nicht gekauft, jetzt geht die wieder hoch 🥴😳

Investitionen in neue Ölprojekte steigen https://www.reuters.com/business/energy/exxon-chevron-spend-billions-more-oil-projects-next-year-2022-12-08/

Blaue Twitter Haken werden für iPhone Besitzer zukünftig 11$ kosten anstatt 8$. So der Plan von Onkel TesTwit laut "the Information" 🤣🤣🤣🤣 Man holt sich also den 30% Anteil den Apple im App-Store kassiert einfach von den iPhone Nutzern zurück um weiterhin 8$ in Twitters Kassen, ääähhhh Elons Schublade zu spülen 😅

Kann mir einer erklären Nvidia +6% und die anderen Chips leicht rot? Wieder im Meme Hype?

Was den hier für Todentanz? Komme gerade vom Weihnachtsmarkt und habe mir auf die Rally gut einen reingebiechelt

Was die machen ne Kapitalerhöhung 🤔 um wo ander sich einzukaufen 🤔

BICO agrees with Sartorius on strategic cooperation, followed by a SEK 487m directed share issue of shares to Sartorius The Board of Directors of BICO Group AB (publ) ("BICO" or the “Company”) has exercised the authorization granted by the Annual General Meeting to issue up to 6,408,626 class B shares (“New Shares”) in full, equivalent to ten percent (10%) of outstanding shares in the company prior to the transaction, through a directed share issue (the “Share Issue”) to Sartorius AG ("Sartorius"). The subscription price of the Share Issue amounts to SEK 76.00 (the “Subscription Price”), equivalent to a premium of 2.7 percent compared to the volume weighted average price of the last three (3) trading days for BICO’s class B shares on Nasdaq Stockholm preceding 8 December (the “3-day VWAP”). Through the Share Issue the Company will receive gross proceeds of approximately SEK 487m, before transaction costs, and will upon settlement result in an ownership for Sartorius of approximately 9.1 percent of the shares and 7.6 percent of the voting rights in BICO, following the transaction. Added to Sartorius' already existing holding in BICO, the total ownership amounts to approximately 10.1 percent of the shares and 8.5 percent of the voting rights. In conjunction with the Share Issue, BICO and Sartorius have agreed on a comprehensive technology as well as sales and marketing cooperation. As part of the partnership, both companies will enter into a research & development collaboration relating to 3D cell printing and associated technologies as well as digital solutions for cell line development workflows. Additionally, it was agreed that Sartorius will become a distributor of BICO products in the Asia-Pacific (APAC) region. “The strategic collaboration with Sartorius is expected to significantly expand our presence and accelerate growth in Asia-Pacific, where BICO today has considerable expansion potential. BICO will get access to value adding, complementary technologies and products, which will enhance our current customer offering within bioprinting and lab automation. We consider the Sartorius ownership in BICO as a verification of the BICO growth strategy,” says Erik Gatenholm, CEO and co-founder of BICO. “The cooperation with BICO will enable us to jointly strengthen our activities in very dynamic fields like advanced cell models and digital workflows in drug research and development. We will further enhance the position of both companies in the fast-growing Asian markets with highly differentiating and relevant technologies. We are convinced that the strategic partnership and the investment in BICO will create value for both parties,” says Gerry Mackay, member of the Executive Board and Head of the Lab Products & Services Division of Sartorius. 🤩